Thomas Kistorp

Copenhagen University Hospital, University of Copenhagen

Papers

3

Total Citations

45

H-Index

2

About

Thomas Kistorp is a pioneering urological surgeon whose research centers on advancing minimally invasive surgical techniques for kidney transplantation and bladder cancer treatment. His work focuses on comparing robot-assisted and open surgical approaches to improve patient outcomes and reduce complications. Kistorp’s most impactful contribution is the BORARC study, a double-blinded, randomised feasibility trial examining robot-assisted versus open radical cystectomy for bladder cancer, which has garnered 41 citations and established new standards for surgical research methodology. He is also leading the ORAKTx trial, a landmark open-label randomised clinical trial investigating whether robot-assisted kidney transplantation can reduce surgical complications compared to the traditional open approach—a study with the potential to transform transplant surgery. Additionally, Kistorp has published protocols integrating Enhanced Recovery After Surgery (ERAS) principles with robotic cystectomy, demonstrating his commitment to holistic surgical innovation. His work, though early in citation accumulation, addresses critical questions in urological oncology and transplantation, positioning him as a rising authority in robotic surgery and evidence-based surgical practice.

Research Focus

Key Achievements

2
H-Index
3
Papers
45
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Open vs robot‐assisted radical cystectomy (BORARC): a double‐blinded, randomised feasibility study
41 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Copenhagen University Hospital, University of Copenhagen

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago